Importantly, reduced Rab35 levels are also observed in hippocampus following Aβ infusion, an experimental model of AD that mimics early AD neuropathology and further stimulates amyloidogenic APP processing [5, 31, 32]. The gene discussed is RAB35; the disease is Alzheimer disease.